InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
3
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Neels Guido J, 董事. Director active across 3 companies, notably Axogen, Inc.. Cumulatively, 19 filings have been recorded. Split: 3 buys · 1 sell. Total volume traded: €125k. Activity tracked since 19 May 2021. The latest transaction was filed on 2 June 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Neels Guido J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
32,282 股0Class A Common StockSEC:0001222362-26-000008:0
6,250 股Class A Common StockSEC:0001222362-26-000006:0
20,000 股@ US$1.0456.8% 占其流量Class A Common StockSEC:0001222362-26-000004:0
标准退出：2026年4月30日 (T+90)
15,000 股@ US$1.0643.2% 占其流量Class A Common StockSEC:0001222362-26-000002:0
标准退出：2026年4月28日 (T+90)
6,250 股Class A Common StockSEC:0001222362-25-000009:0
4,073 股@ US$10.6115.1% 占其流量Common StockSEC:0000805928-25-000082:0
26,493 股0Class A Common StockSEC:0001578563-25-000307:0
11,904 股0Common StockSEC:0000805928-24-000120:0
30,400 股0Class A Common StockSEC:0001578563-24-000269:0
10,653 股Common StockSEC:0000805928-24-000093:0
10,000 股@ US$6.1115.3% 占其流量Common StockSEC:0000805928-23-000099:0
标准退出：2023年11月14日 (T+90)
16,648 股0Class A Common StockSEC:0001578563-23-000041:0
6,459 股0Common StockSEC:0000805928-23-000064:0
3,036 股0Common StockSEC:0000805928-22-000064:0
2,700 股Class A Common StockSEC:0000899243-22-013957:0
9,000 股Class A Common StockSEC:0000899243-22-006552:0
25,000 股@ US$3.800.0051% mcap25.0% 占其流量Common StockSEC:0000805928-21-000115:0
6,173 股0Common StockSEC:0000805928-21-000108:0
25,000 股@ US$3.8031.2% 占其流量Common StockSEC:0000805928-21-000096:0
19 条申报中的 19 条
About Neels Guido J
Administrateur, NEELS GUIDO J has made 19 filings in total. Among the recent filings available, they cover the period from 2021-05-21 to 2026-06-04, with buys of EUR 86798 and sells of EUR 37814. They are a director of Axogen, Inc., Bioventus Inc. and ELUTIA INC., and the most frequent transaction nature is option exercise.
